Frontline setting accelerates potential for deep, durable responses in the treatment of liver cancers Study builds on clinical validation from one of the largest datasets in the in vivo CAR field ...
90% of frontline AML patients achieved remission with mipletamig plus ven/aza, surpassing the 66% rate seen with ven/aza alone. No cytokine release syndrome (CRS) has been reported in the RAINIER ...
Kura Oncology holds a strong cash position with Komzifti FDA approval and frontline AML expansion potential. Read why KURA ...
Fifteen healthcare organizations, including Loma Linda University Medical Center, have been selected to participate in a national study intended to enhance patient safety and quality of care in health ...
100 percent of evaluable patients for minimal residual disease (MRD) testing achieved MRD negativity in MajesTEC-5 as induction therapy and MajesTEC-4 as maintenance therapy "These data from the ...
The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Jacob Kupietzky While ...
NEW ORLEANS ― An interdisciplinary pilot program effectively deals with behavioral disturbances arising from delirium, dementia, or other mental illnesses in hospitalized older adults ― while keeping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results